The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphism
Open accessAbstract
BACKGROUND: Polymorphisms of the beta(2) adrenoceptor influence receptor function in vitro and asthma phenotypes in vivo. However, their importance in determining responses to inhaled beta agonist treatment has not been clearly defined. METHODS: In a retrospective analysis of previously published data we have examined relationships between polymorphisms at codons 16 and 27 of the beta(2) adrenoceptor and clinical outcomes in a randomised, placebo controlled, crossover trial of regularly scheduled salbutamol and salmeterol in 115 patients with mild to moderate asthma. Genotyping was obtained for positions 16 and 27 in 108 and 107 patients, respectively. For position 16, 17 patients (16%) were homozygous Arg-Arg, 40 (37%) were heterozygous Arg-Gly, and 51 (47%) were homozygous Gly-Gly. RESULTS: Within the homozygous Arg-16 group major exacerbations were more frequent during salbutamol treatment than with placebo (1.91 (95% CI 1.07 to 3.12) per year versus 0.81 (95% CI 0.28 to 1.66) per year; p = 0.005). No significant treatment related differences occurred for heterozygous Arg-Gly patients (salbutamol 0.11 (95% CI 0.01 to 0.40), placebo 0.54 (95% CI 0.26 to 1.00) exacerbations per year) or homozygous Gly-16 patients (salbutamol 0.38 (95% CI 0.17 to 0.73), placebo 0.30 (95% CI 0.12 to 0.61) exacerbations per year). No adverse changes occurred for any position 16 subgroup with salmeterol. There was no significant relationship between position 27 genotypes and treatment related outcomes. CONCLUSION: Homozygous Arg-16 patients are susceptible to clinically important increases in asthma exacerbations during chronic dosing with the short acting beta(2) agonist salbutamol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
Pauwels, R. A., Löfdahl, C.-G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372001 · Cited by 1,520
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
(1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380222 · Cited by 864
Green, S. A., Turki, J., Innis, M., & Liggett, S. B. (1994) · Biochemistry · doi:10.1021/bi00198a006 · Cited by 772
Martinez, F. D., Graves, P. E., Baldini, M., Solomon, S., & Erickson, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119874 · Cited by 605
ISRAEL, E., DRAZEN, J. M., LIGGETT, S. B., BOUSHEY, H. A., CHERNIACK, R. M., CHINCHILLI, V. M., COOPER, D. M., FAHY, J. V., FISH, J. E., FORD, J. G., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9907092 · Cited by 549
Allergic respiratory disease: strategic targets for primary prevention during childhood
Holt, P. G., & Sly, P. D. (1997) · Thorax · doi:10.1136/thx.52.1.1 · Cited by 464
The British Guidelines on Asthma Management * 1995 Review and Position Statement
The British Thoracic Society The National Asthma Campaign The Royal College of Physicians of London in association with the General Practitioner in Asthma Group the British Association of Accident and Emergency Medicine the British Paediatric Respiratory (1997) · Thorax · doi:10.1136/thx.52.suppl_1.s1 · Cited by 448
Green, S. A., Turki, J., Bejarano, P., Hall, I. P., & Liggett, S. B. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.1.7598936 · Cited by 439
Turki, J., Pak, J., Green, S. A., Martin, R. J., & Liggett, S. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117838 · Cited by 397
Tan, S., Hall, I. P., Dewar, J., Dow, E., & Lipworth, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03211-x · Cited by 337
Cited by
Pharmacology and Therapeutics of Bronchodilators
Cazzola, M., Page, C. P., Calzetta, L., & Matera, M. G. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004580 · Cited by 467
Dishy, V., Sofowora, G. G., Xie, H.-G., Kim, R. B., Byrne, D. W., Stein, C. M., & Wood, A. J. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010819 · Cited by 363
Pharmacology and physiology of human adrenergic receptor polymorphisms
Small, K. M., McGraw, D. W., & Liggett, S. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135823 · Cited by 323
McFadden, E. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-902so · Cited by 317
Ortega, V. E., & Meyers, D. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.040 · Cited by 237
Metadata
- Authors
- Taylor, D. R.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2000-09-01
- Volume
- 55
- Issue
- 9
- Pages
- 762-767
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2152785448
- Cited by
- 347
- References
- 19
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphism. https://app.cochat.ai/papers/10.1136/thorax.55.9.762
- The paper
- Taylor, D. R. (2000). Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphism. Thorax. https://doi.org/10.1136/thorax.55.9.762
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.